Sorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron and Omicron (+R346k) Variants of Sars-Cov-2

Press/Media

Period21 Jan 2022

Media coverage

1

Media coverage

  • TitleSorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron and Omicron (+R346k) Variants of Sars-Cov-2
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date21/01/22
    PersonsDomenico Tortorella